These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23674772)

  • 1. MR imaging of prostate cancer in radiation oncology: what radiologists need to know.
    Boonsirikamchai P; Choi S; Frank SJ; Ma J; Elsayes KM; Kaur H; Choi H
    Radiographics; 2013 May; 33(3):741-61. PubMed ID: 23674772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: MR imaging of prostate cancer in radiation oncology: what radiologists need to know.
    Siegel C
    J Urol; 2014 Aug; 192(2):423-4. PubMed ID: 25034994
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of Prostate MR Imaging in Radiation Oncology.
    Ménard C; Paulson E; Nyholm T; McLaughlin P; Liney G; Dirix P; van der Heide UA
    Radiol Clin North Am; 2018 Mar; 56(2):319-325. PubMed ID: 29420985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
    Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
    Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-based brachytherapy: a forum for collaboration between radiation oncologists and diagnostic radiologists.
    Erickson B
    J Am Coll Radiol; 2005 Sep; 2(9):753-8. PubMed ID: 17411923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of CT imaging for postplan quality assessment in prostate brachytherapy.
    Petrik D; Araujo C; Kim D; Halperin R; Crook JM
    Brachytherapy; 2012; 11(6):435-40. PubMed ID: 22732323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer.
    Morgia M; Cuartero J; Walsh L; Jezioranski J; Keeler K; Xie J; Massey C; Williamson D; Cho YB; Oh S; Fyles A; Milosevic M
    Radiother Oncol; 2013 Apr; 107(1):46-51. PubMed ID: 23540555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance-guided adaptive radiotherapy: a solution to the future.
    Kupelian P; Sonke JJ
    Semin Radiat Oncol; 2014 Jul; 24(3):227-32. PubMed ID: 24931098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in highly conformal radiotherapy for prostate cancer: past, current, and future].
    Ishikawa H; Hashimoto T; Makishima H; Mizumoto M; Okumura T; Sakurai H
    Igaku Butsuri; 2012; 32(3):138-47. PubMed ID: 24592684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
    Al-Salihi O; Mitra A; Payne H
    Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of magnetic resonance imaging for radiotherapy planning.
    Dirix P; Haustermans K; Vandecaveye V
    Semin Radiat Oncol; 2014 Jul; 24(3):151-9. PubMed ID: 24931085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans.
    Jani AB; Hand CM; Lujan AE; Roeske JC; Zagaja GP; Vijayakumar S; Pelizzari CA
    Med Dosim; 2004; 29(1):42-8. PubMed ID: 15023392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT and radiotherapy in prostate cancer.
    De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma.
    Lim C; Malone SC; Avruch L; Breau RH; Flood TA; Lim M; Morash C; Quon JS; Walsh C; Schieda N
    Br J Radiol; 2015 Oct; 88(1054):20150507. PubMed ID: 26279086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage therapy for locally recurrent prostate cancer after radiation.
    Marcus DM; Canter DJ; Jani AB; Dobbs RW; Schuster DM; Carthon BC; Rossi PJ
    Can J Urol; 2012 Dec; 19(6):6534-41. PubMed ID: 23228288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.
    Yakar D; Hambrock T; Huisman H; Hulsbergen-van de Kaa CA; van Lin E; Vergunst H; Hoeks CM; van Oort IM; Witjes JA; Barentsz JO; Fütterer JJ
    Invest Radiol; 2010 Mar; 45(3):121-5. PubMed ID: 20065860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.